FINISHING an eight-mile run, Tracy Hughes walks into her bathroom and turns on the shower. Wearing her form-fitting exercise kit, the mum-of-four has a svelte

submitted by /u/mvea [link] [comments]

(MedPage Today) — You passed medical training, now see if you can pass our weekly quiz

Post Content

(NaturalNews) Ozempic/Wegovy users risk losing muscle, bone mass and mental health as severe side effects. GLP-1 drugs linked to 62,000 adverse events and 16…

“Pharmacist Holding a Box of Ozempic” by chemist4u, CC BY 2.0 “O God, give us the serenity to accept what cannot be changed, the courage

Omada Health Shares Soar After IPO as GLP-1 Drugs Fuel Interest  WSJ Omada shares rise 21% in Nasdaq debut after health tech company’s IPO  CNBC Omada Health

The producer of Ozempic was advised to list the serious eye condition as a side effect The European Medicines Agency (EMA) has concluded that semaglutide-based

GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs

The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in

“I want to know I’m doing absolutely everything I can to preserve my health for as long as possible.” We hear this kind of thing

Eighty-five percent of US GLP-1 drug consumers report major changes in their food and beverage preferences after starting the medications, says a new report from

An obesity and internal medicine specialist based in New York, Dr Alexandra Sowa has been researching and practising obesity medicine for about a decade now.

FRIDAY, June 6, 2025 — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident

Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide products, Wegovy (obesity) and Ozempic (diabetes).

The European Medicines Agency said Friday that the product information for Novo Nordisk’s Ozempic and Wegovy should be updated to list a serious eye condition

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss

(MedPage Today) — A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines

Ozempic, Wegovy, Mounjaro, and all the other new GLP-1 weight loss drugs are able to miraculously shed pounds. But it seems like they may be

Publication date: Available online 6 June 2025 Source: Bioorganic & Medicinal Chemistry Author(s): Chengcheng Wang, Jinhua Zhang, Yuanzhen Dong, Jun Xu, Jianguang Lu, Chunyong Ding,

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

Patients taking weight-loss and diabetes drugs Wegovy and Ozempic have an increased risk of developing a rare eye condition that could lead to loss of

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, happy Friday!

In the study, diabetes patients who took GLP-1s were twice as likely to develop neovascular age-related macular degeneration (nAMD) than those without GLP-1 exposure.

People using GLP-1 drugs are reporting an unusual side effect impacting dental health that some are calling “Ozempic teeth.” Jacob Wackerhausen/Getty Images People using GLP-1

While Ozempic and other weight-loss drugs have been shown to have myriad benefits, they can also present some unwelcome effects, primarily nausea, vomiting and other

(MedPage Today) — Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their risk of developing neovascular age-related

Study finds medicines such as Ozempic associated with greater risk of developing age-related macular degeneration Weight loss drugs could at least double the risk of

GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds  statnews.com Weight loss drugs linked to higher risk of eye damage in

Anecdotes abound about “Ozempic babies”—when women wound up with unplanned pregnancies while taking both birth-control and the popular GLP-1 drugs for diabetes or weight loss. 

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness,

Women using GLP-1 weight-loss drugs must use effective contraception, the MHRA has warned, citing unknown risks to pregnancy and foetal health. Medscape News UK

Women in bathing suits lined up on the beach in 1949. | FPG/Getty Images For decades, women have heard about the mythical “summer body” —

GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications seeing weight reductions of 5%–18% in clinical trials, along